skip to main content
Show Results with: Show Results with:

Medical Comorbidity is Associated with Persistent Index Hip Pain after Total Hip Arthroplasty

Singh, Jasvinder A.; Lewallen, David G.

Pain medicine. Volume 14:Issue 8 (2013); pp 1222-1229 -- Oxford University Press

Online access

  • Title:
    Medical Comorbidity is Associated with Persistent Index Hip Pain after Total Hip Arthroplasty
  • Author: Singh, Jasvinder A.;
    Lewallen, David G.
  • Found In: Pain medicine. Volume 14:Issue 8 (2013); pp 1222-1229
  • Journal Title: Pain medicine
  • Subjects: Analgésiques--Périodiques; Douleur--Périodiques; Douleur--Traitement--Périodiques; Analgésique; Périodique électronique (Descripteur de forme); Ressource Internet (Descripteur de forme); Soulagement de la douleur; Pain Management--Periodicals; Analgesics--Periodicals; Pain--Periodicals; Pain--Treatment--Periodicals; Dewey: 616.047205
  • Rights: legaldeposit
  • Publication Details: Oxford University Press
  • Abstract: Abstract Objective

    To characterize whether medical comorbidity predicts persistent moderate‐severe pain after total hip arthroplasty (THA).

    Methods

    We analyzed the prospectively collected data from the Mayo Clinic Total Joint Registry for patients who underwent primary or revision THA between 1993 and 2005. Using multivariable‐adjusted logistic regression analyses, we examined whether certain medical comorbidities were associated with persistent moderate‐severe hip pain 2 or 5 years after primary or revision THA. Odds ratios (ORs), along with 95% confidence intervals (CIs) and P value, are presented.

    Results

    The primary THA cohort consisted of 5, 707 THAs and 3, 289 THAs at 2 and 5 years, and revision THA, 2, 687 and 1, 627 THAs, respectively. In multivariable‐adjusted logistic regression models, in the primary THA cohort, renal disease was associated with lower odds of moderate‐severe hip pain (OR 0.6; 95% CI 0.3, 1.0) at 2 years. None of the comorbidities were significantly associated at 5 years. In the revision THA cohort, heart disease was significantly associated with higher risk (OR 1.7; 95% CI 1.1, 2.6) at 2 years and connective tissue disease with lower risk (OR 0.5; 95% CI 0.3, 0.9) of moderate‐severe hip pain at 5‐year follow‐up.

    Conclusion

    This study identified new correlates of moderate‐severe hip pain after primary or revision THA, a much‐feared outcome of hip arthroplasty. Patients with these comorbidities should be informed regarding the risk of moderate‐severe index hip pain, so that they can have a fully informed consent and realistic expectations.


  • Identifier: ETOClsidyv7c2bd1b4; System Number: LDEAvdc_100024538863.0x000001; Journal ISSN: 1526-2375; 10.1111/pme.12153
  • Publication Date: 2013
  • Physical Description: Electronic
  • Shelfmark(s): ELD Digital store

Searching Remote Databases, Please Wait